Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 40% ± 16% | |
GABAergic neuron | 5 studies | 34% ± 13% | |
retinal ganglion cell | 4 studies | 40% ± 24% | |
neuron | 3 studies | 30% ± 11% | |
interneuron | 3 studies | 37% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 31% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 52574.88 | 2600 / 2642 | 100% | 123.80 | 705 / 705 |
adrenal gland | 93% | 3687.49 | 241 / 258 | 98% | 59.48 | 226 / 230 |
prostate | 75% | 2543.39 | 183 / 245 | 100% | 43.73 | 501 / 502 |
ovary | 74% | 2458.39 | 133 / 180 | 100% | 33.01 | 428 / 430 |
thymus | 72% | 2481.72 | 473 / 653 | 100% | 43.17 | 604 / 605 |
uterus | 69% | 2314.95 | 118 / 170 | 98% | 25.17 | 452 / 459 |
bladder | 57% | 1836.62 | 12 / 21 | 97% | 22.18 | 487 / 504 |
esophagus | 43% | 1389.75 | 620 / 1445 | 100% | 27.61 | 183 / 183 |
intestine | 42% | 1370.07 | 410 / 966 | 97% | 18.27 | 510 / 527 |
skin | 30% | 1072.74 | 544 / 1809 | 100% | 48.25 | 472 / 472 |
lung | 28% | 852.59 | 162 / 578 | 98% | 24.52 | 1128 / 1155 |
stomach | 26% | 831.50 | 93 / 359 | 97% | 19.51 | 276 / 286 |
kidney | 22% | 750.31 | 20 / 89 | 97% | 19.88 | 877 / 901 |
breast | 17% | 529.10 | 78 / 459 | 99% | 40.29 | 1110 / 1118 |
eye | 0% | 0 | 0 / 0 | 100% | 41.91 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.96 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.75 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.96 | 1 / 1 |
pancreas | 2% | 43.75 | 5 / 328 | 97% | 21.80 | 172 / 178 |
liver | 3% | 90.27 | 7 / 226 | 54% | 8.72 | 219 / 406 |
heart | 49% | 1645.89 | 426 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 44% | 1383.02 | 583 / 1335 | 0% | 0 | 0 / 0 |
spleen | 19% | 530.37 | 46 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 14% | 518.86 | 131 / 929 | 0% | 0 | 0 / 0 |
adipose | 9% | 274.09 | 109 / 1204 | 0% | 0 | 0 / 0 |
muscle | 7% | 208.35 | 56 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048168 | Biological process | regulation of neuronal synaptic plasticity |
GO_0045453 | Biological process | bone resorption |
GO_0031175 | Biological process | neuron projection development |
GO_0043204 | Cellular component | perikaryon |
GO_0010008 | Cellular component | endosome membrane |
GO_0030424 | Cellular component | axon |
GO_0005634 | Cellular component | nucleus |
GO_0005829 | Cellular component | cytosol |
GO_0030425 | Cellular component | dendrite |
GO_0098794 | Cellular component | postsynapse |
GO_0043025 | Cellular component | neuronal cell body |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | NCDN |
Protein name | Neurochondrin |
Synonyms | KIAA0607 |
Description | FUNCTION: Probably involved in signal transduction in the nervous system, via increasing cell surface localization of GRM5/mGluR5 and positively regulating its signaling . Required for the spatial learning process. Acts as a negative regulator of Ca(2+)-calmodulin-dependent protein kinase 2 (CaMK2) phosphorylation. May play a role in modulating melanin-concentrating hormone-mediated functions via its interaction with MCHR1 that interferes with G protein-coupled signal transduction. May be involved in bone metabolism. May also be involved in neurite outgrowth (Probable). . |
Accessions | ENST00000373243.7 [Q9UBB6-1] ENST00000356090.8 [Q9UBB6-1] C9J5H8 ENST00000423723.1 ENST00000373253.7 [Q9UBB6-2] H7C2R2 Q9UBB6 ENST00000437806.1 |